NCT00567567 · OUTCOME

Type of Surgical or Radiotherapy Complication

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: Percentage of patients
Interval / dispersion: Not reported
Time frame: Up to 3 years

What was measured

The Percentage of patients who experienced surgical or radiotherapy complications will be calculated. The complications are: bowel obstruction, chylous leaf, renal injury/atrophy/loss and diarrhea.

Analysis population: All eligible patients enrolled on ANBL0532.

Groups in this outcome

Single HST (CEM)

Induction therapy + single myeloablative consolidation

Tandem HST (CEM), Randomly Assigned

Induction therapy + tandem myeloablative consolidation

Not Assigned

Patients that either failed during Induction therapy or refused randomization

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Single HST (CEM)	206
Tandem HST (CEM), Randomly Assigned	176
Not Assigned	270

Reported measurements

Source class 1

Values in Percentage of patients · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Single HST (CEM)	13.11	Not reported	Not reported	Not reported	Not reported
Tandem HST (CEM), Randomly Assigned	12.50	Not reported	Not reported	Not reported	Not reported
Not Assigned	11.85	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
13.11
group Id
OG001
value
12.50
group Id
OG002
value
11.85

denoms

counts
group Id
OG000
value
206
group Id
OG001
value
176
group Id
OG002
value
270
units
Participants

description

The Percentage of patients who experienced surgical or radiotherapy complications will be calculated. The complications are: bowel obstruction, chylous leaf, renal injury/atrophy/loss and diarrhea.

groups

description
Induction therapy + single myeloablative consolidation
id
OG000
title
Single HST (CEM)
description
Induction therapy + tandem myeloablative consolidation
id
OG001
title
Tandem HST (CEM), Randomly Assigned
description
Patients that either failed during Induction therapy or refused randomization
id
OG002
title
Not Assigned

param Type

NUMBER

population Description

All eligible patients enrolled on ANBL0532.

reporting Status

POSTED

time Frame

Up to 3 years

title

Type of Surgical or Radiotherapy Complication

type

SECONDARY

unit Of Measure

Percentage of patients

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice